Welcome to our dedicated page for AUNA S.A. news (Ticker: AUNA), a resource for investors and traders seeking the latest updates and insights on AUNA S.A. stock.
Auna S.A. (AUNA) is a leading Latin American healthcare provider operating hospitals, clinics, and specialized health plans across Peru, Colombia, and Mexico. This page aggregates official company announcements and verified news updates for stakeholders tracking its market position and strategic initiatives.
Investors and analysts will find timely updates on earnings reports, regional expansions, and regulatory developments, while media professionals can monitor operational milestones like new facility openings or partnership agreements. All content is sourced directly from company communications and reputable financial publications.
Key coverage areas include oncology service updates through Oncosalud Peru, prepaid health plan innovations, and cross-border operational developments. Bookmark this page for efficient access to AUNA's latest financial performance data, leadership changes, and healthcare service enhancements across its multinational network.
Auna (NYSE: AUNA) reported 3Q25 consolidated revenue of S/1,117 million (+1% FXN, -1% YoY) and Adjusted EBITDA of S/232 million (Adjusted EBITDA margin 20.8%, down 1.3 p.p. YoY).
Adjusted Net Income was S/58 million versus S/75 million in 3Q24 and consolidated leverage remained at 3.6x Net Debt/Adjusted EBITDA. Regional performance diverged: Peru revenue +9% LC and Adjusted EBITDA +15% LC; Colombia revenue +4% LC and Adjusted EBITDA +18% LC; Mexico revenue fell 12% and Adjusted EBITDA declined 29% (Mexico affected by slower procedure demand and IT implementation issues).
Post-quarter, Auna completed a USD 765 million debt refinancing and announced strategic partnerships to support Mexico recovery and medium-term deleveraging toward below 3x.
Auna (AUNA) announced on November 20, 2025 a Memorandum of Understanding with Sojitz Corporation of America to explore joint healthcare business opportunities across Latin America, with an initial focus on Mexico.
The companies said the collaboration will combine Auna’s healthcare and operational expertise with Sojitz’s investment capabilities and international network to accelerate development of scalable healthcare infrastructure and services. Auna reiterated its prior plan to invest approximately US$500 million over the next three to five years to expand its integrated healthcare platform in Mexico.
Auna (NYSE:AUNA) announced that EsSalud has formally received the construction license for Torre Trecca, a high-rise outpatient center Auna will rebuild and operate under the existing public–private partnership.
Torre Trecca is expected to serve more than 6 million EsSalud-insured Lima residents and accommodate over 3 million visits annually. The license delivery was marked by a ceremony with EsSalud, ProInversión and local officials.
An amendment to the PPP contract is expected to receive final approval by year-end 2025, enabling construction to begin in 2026. Auna reiterated its commitment to expanding access to high-quality healthcare in Lima.
Auna (AUNA) closed a US$765 million debt refinancing on November 7, 2025, issuing US$365 million of 8.75% Senior Secured Notes due November 6, 2032 and a new US$400 million equivalent MXN Term Loan maturing October 15, 2030, with an expected incremental US$60 million tranche in Peruvian Soles.
Proceeds funded a tender for its 10% Senior Secured Notes due 2029, prepaid the November 10, 2023 credit agreement, paid fees/expenses and repaid short-term debt. The deal extends debt maturities, lowers interest expense, improves liquidity and supports a medium target of 3.0x Net Debt-to-EBITDA (versus 3.6x at 2Q 2025). S&P and Fitch assigned a B+ rating to the 2032 Notes. IFC participated as a lead investor and contributed to the Term Loan facility.
Auna (NYSE: AUNA) priced U.S.$365,000,000 of 8.750% Senior Secured Notes due November 6, 2032, issued by Auna and Oncosalud as co‑issuers at 100.000% of principal. The offering includes U.S.$328,500,000 in a Rule 144A/Reg S private placement and U.S.$36,500,000 sold to International Finance Corporation in a concurrent private placement.
Settlement is expected on November 6, 2025, subject to customary closing conditions. Proceeds will be used to fund a tender offer for the company’s 10.000% Senior Secured Notes due 2029 and to prepay indebtedness under the November 10, 2023 credit agreement, plus related interest, fees and expenses. The notes and guarantees are unregistered under the Securities Act and offered only to qualified purchasers under applicable exemptions.
Auna (NYSE:AUNA) announced early results of its cash tender offer and consent solicitation for its 10.000% Senior Secured Notes due 2029 on November 3, 2025.
As of the Early Tender Date (October 31, 2025) US$273,709,580 (about 73.39% of US$372,937,161 outstanding) were validly tendered. The Total Consideration for valid early tenders is US$1,070 per US$1,000 including a US$50 Early Tender Payment; accrued interest also payable. The company obtained consents of a majority of holders; acceptance remains subject to conditions including a Proposed New Notes Offering and customary closing conditions.
Auna (NYSE:AUNA) announced its Third Quarter 2025 financial reporting schedule: an earnings release on Thursday, November 20, 2025 after market close and a conference call on Friday, November 21, 2025 at 8:00 a.m. ET. Auna also set a quiet period from Thursday, November 13 through Thursday, November 20, 2025. Investors can join by phone at +1 888 596 4144 (toll-free) or +1 646 968 2525 (international) using entry passcode 3884034, and via webcast.
Auna (NYSE: AUNA) announced that it and Oncosalud will seek to privately offer senior secured notes due 2032 to qualified institutional buyers under Rule 144A and to non-U.S. persons under Regulation S.
The Notes are expected to be fully and unconditionally guaranteed on a senior secured basis by certain subsidiaries. Proceeds will be used to (i) fund a tender offer to purchase any and all of its 10.000% Senior Secured Notes due 2029 and (ii) prepay indebtedness under the credit agreement dated November 10, 2023, plus related interest, fees and expenses. Timing, pricing and terms are subject to market conditions.
Auna (NYSE:AUNA) commenced a cash tender offer and consent solicitation for any and all of its outstanding 10.000% Senior Secured Notes due 2029, with U.S.$372,937,161 principal outstanding. The company is offering U.S.$1,070 per U.S.$1,000 principal (including a U.S.$50 early tender payment) for notes validly tendered by the Early Tender Date of October 31, 2025. The Tender Offer expires at 5:00 p.m. NY time on November 18, 2025, with expected early settlement on November 6, 2025 and final settlement on November 21, 2025. The purchase is conditioned on receiving majority consents and successful execution of a Proposed New Notes Offering and a Proposed Term Loan.
Auna (NYSE:AUNA), a Latin American healthcare provider, announced significant expansion of its OncoMexico insurance network through strategic partnerships with leading medical institutions across Mexico's major urban centers. The company has partnered with prominent healthcare facilities including Médica Sur in Mexico City, San Javier in Guadalajara, and Simnsa in Tijuana, among others.
The company plans to invest approximately US$500 million in Mexico's principal cities over the next 3-5 years. To fund this expansion and improve its capital structure, Auna will meet with debt and equity investors to explore financing options, aiming to maintain leverage at 3x Net Debt-to-EBITDA. Additionally, following its listing on the Lima Stock Exchange, Auna meets eligibility criteria for inclusion in three MSCI indices.
FAQ
What is the current stock price of AUNA S.A. (AUNA)?
What is the market cap of AUNA S.A. (AUNA)?
